Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro

Early diagnosis and therapy in the first stages of a malignant disease is the most crucial factor for successful cancer treatment and recovery. Currently, there is a high demand for novel diagnostic tools that indicate neoplasms in the first or pre‑malignant stages. MicroRNAs (miRNA or miR) are smal...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular medicine reports 2020-11, Vol.22 (5), p.4048-4060
Hauptverfasser:	Hirschfeld, Marc, Ge, Isabel, Rücker, Gerta, Waldschmidt, Julia, Mayer, Sebastian, Jäger, Markus, Voigt, Matthias, Kammerer, Bernd, Nöthling, Claudia, Berner, Kai, Weiss, Daniela, Asberger, Jasmin, Erbes, Thalia
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Biomarkers Biomarkers, Tumor - genetics Biopsy Breast Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - genetics Cancer diagnosis Cancer research Cancer treatment Cell Line, Tumor Diagnosis, Differential Early Detection of Cancer Endometrial cancer Endometrial Neoplasms - diagnosis Endometrial Neoplasms - genetics Endometrium Female Gene Expression Profiling - methods Gene Expression Regulation, Neoplastic Genes Genetic aspects Humans Investigations Kinases Medical diagnosis MicroRNA MicroRNAs - genetics miRNA Neoplasia Non-coding RNA Ovarian cancer Ovarian Neoplasms - diagnosis Ovarian Neoplasms - genetics Reverse transcription Scientific equipment industry Tumor suppressor genes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!